Our Strategy
Our Sustainability (ESG) strategy is aligned to net zero 2050 across all scopes via the Science Based Targets Initiative (SBTi – which we received validation for in May 2024), and targets to increase the proportion of sustainable products – which support CO2 reduction or bring clinical benefit – as well as minimising use of resources such as energy, waste and water. 100% of our global electricity is from renewable sources, some including our own solar electricity generation.
Our strategy has Sustainability at its core and seeks to build on the competitive advantage we already offer to our customers and our markets. Our focus is on three key areas: People, Planet, and Products.
